Recent Finacing
Recent Raise
Progentec develops CLIA‑lab–anchored biomarker diagnostic tests and digital platforms for lupus, including pre-symptom detection, disease‑activity monitoring and prediction, a biomarker activity index, and patient-facing management tools.
